SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹122 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr | ₹216 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹176 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹154 Cr |
Mar2020 | ₹216 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | -30.56 | |
Mar2023 | ₹176 Cr | -15.92 | |
Mar2022 | ₹209 Cr | 36.16 | |
Mar2021 | ₹154 Cr | -29.05 | |
Mar2020 | ₹216 Cr | - |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,223.8 Cr | 9.9% | 33.4% | 36.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 9.9% |
33.4% |
36.5% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses